Long-acting insulin helps people with diabetes maintain normal blood sugar levels throughout the day. Unlike short-acting insulin, it never peaks, keeping an even sugar level in your blood.

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ... the U.S., following the approval of two long-acting insulin biosimilars in 2021.

The places where you inject insulin may depend on the type of syringe or prefilled insulin pen you use ... it might not last as long, and the injection is usually more painful.

But it looks unlikely that Lilly will be able to maintain this with the launch of Humalog, which is available in vial form or as a disposable pen ... and its long-acting insulin Tresiba (insulin ...

Once you open a vial of insulin or pen, another expiration date starts. Generally, insulin expires 28 days after it's opened (for a vial or pen), says Fernandez de Fiore, but some pens only last 7 ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Trials including commercially available formulations of insulin detemir or insulin glargine were compared with NPH. Pertinent English-language clinical trials published between 2000 and 2006 were ...

The list price of Basaglar will be $316.85 for a pack of five pens, 15% below the list ... undercutting the long-acting Levemir (insulin detemir) by 21% and Tresiba (insulin degludec) an ultra ...

To mimic physiological insulin release, both long-acting and short-acting insulin ... we introduced the world’s first pen-shaped devices for subcutaneous injection in 1985.